CD93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp), is
a transmembrane glycoprotein encoded by a gene located on 20p11. 21 and composed of …

The challenges associated with diagnosing and treating cardiovascular disease
(CVD)/Stroke in Rheumatoid arthritis (RA) arise from the delayed onset of symptoms …

Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases,
which are increasing in prevalence. However, the failure of conventional lipid-lowering …

Background Tobacco use is known to be involved in the development of cardiovascular
diseases, which leads to premature mortality. Endothelial dysfunction, the first step in this …

Introduction. Cluster of Differentiation (CD) 93 (also known as complement protein 1 q
subcomponent receptor C1qR1 or C1qRp) is a transmembrane glycoprotein that can also …

As an end product of purine metabolism, uric acid (UA) is a major endogenous antioxidant in
humans. However, impaired UA synthesis and excretion can lead to hyperuricemia (HUA) …

Vascular aging is an important factor contributing to cardiovascular diseases, such as
hypertension and atherosclerosis. Hyperlipidemia or fatty accumulation may play an …

Simple Summary In this review paper, we discuss potential new therapies for ischemic heart
disease (IHD), a leading cause of death and disability around the world. IHD results from a …

Olive oil production yields a substantial volume of by‐products, constituting up to 80% of the
processed fruits. The olive pomace by‐product represents a residue of significant interest …

Metabolic syndrome (MetS) is a multifaceted condition that increases the possibility of
developing atherosclerotic cardiovascular disease. MetS includes obesity, hypertension …